A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Clinical trial NCT05432492 · COMPLETED

Trial details

NCT number: NCT05432492
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-08-03
Primary completion: 2025-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.